Return to search

Ascus Biosciences fetches $46m Series B

San Diego-based Ascus Biosciences, an animal health and nutrition company, has raised $46 million in Series B funding.

San Diego-based Ascus Biosciences, an animal health and nutrition company, has raised $46 million in Series B funding. Temasek led the round with participation from other investors that included Anterra Capital, Formation 8 and Cavallo Ventures.

Source: Press Release